(Journal of the National Cancer Institute) Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published Sept. 9 in the Journal of the National Cancer Institute.
cervarixFewer than 3 doses of cervical cancer vaccine effectiveEurekAlert! - Cancer Thu, 09/08/2011 - 22:00
Tags:
Eight HPV types cause majority of cervical cancer cases: studyNYDailyNews.com - Health - NY Daily News Mon, 10/18/2010 - 10:18
GSK's Cervarix and Merck's Gardasil protect against HPV types 16 and 18; future vaccines could protect against whole spectrum. Protection from HPV Vaccine Lasts Longer than Six Years (CME/CE)MedPage Today Infectious Disease Wed, 12/02/2009 - 16:30
Cervarix, one of two FDA-approved vaccines against human papillomavirus (HPV), protects against infection for more than six years, researchers found. |
